PUBLISHER: The Business Research Company | PRODUCT CODE: 2132049
PUBLISHER: The Business Research Company | PRODUCT CODE: 2132049
Medical plastic extrusion is a specialized production technique used to manufacture continuous plastic components by processing medical-grade polymer materials through a customized die. This process is extensively used in the healthcare sector to create accurate, sterile, and durable medical products that comply with strict quality and regulatory requirements. It supports the production of components used in applications such as fluid management systems, diagnostic devices, minimally invasive medical procedures, and patient care solutions.
The primary product types of medical plastic extrusion include tubing, catheters, disposables, and other product types. Tubing refers to extruded medical plastic components designed for fluid transfer, drug delivery, and diagnostic applications due to their flexibility, durability, and biocompatibility. These products are manufactured using materials such as polyvinyl chloride, polyethylene, polypropylene, polycarbonate, and other materials and are distributed through direct sales, distributors and wholesalers, and online sales. The primary applications include medical devices, packaging, diagnostics, and others, while the primary end users are hospitals, clinics, ambulatory surgical centers, and others.
Tariffs are influencing the medical plastic extrusion market by increasing the cost of imported medical-grade polymers, extrusion equipment, and specialized manufacturing components required for healthcare product production. The impact is considerable across regions such as North America, Europe, and Asia-Pacific, where medical device manufacturers rely on global supply chains for raw materials and processing technologies. Segments including tubing, catheters, disposables, and diagnostic components are most affected due to their dependence on high-quality polymer materials and precision manufacturing processes. However, tariffs are also encouraging domestic polymer production, regional supplier diversification, and investments in local medical device manufacturing capabilities.
The medical plastic extrusion market research report is one of a series of new reports from The Business Research Company that provides medical plastic extrusion market statistics, including medical plastic extrusion industry global market size, regional shares, competitors with a medical plastic extrusion market share, detailed medical plastic extrusion market segments, market trends and opportunities, and any further data you may need to thrive in the medical plastic extrusion industry. This medical plastic extrusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical plastic extrusion market size has grown strongly in recent years. It will grow from $4.97 billion in 2025 to $5.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period was driven by increasing demand for disposable medical devices, rising adoption of minimally invasive procedures, growing expansion of healthcare infrastructure, increasing use of plastic components in medical applications, and rising need for cost-effective medical manufacturing solutions.
The medical plastic extrusion market size is expected to see strong growth in the next few years. It will grow to $6.82 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for customized medical extrusion products, rising adoption of advanced biocompatible polymers, growing investments in medical device manufacturing, expanding applications of extrusion technology in diagnostics and patient care, and increasing focus on sustainable medical plastic solutions. Major trends in the forecast period include increasing demand for precision medical plastic extrusion solutions, growing adoption of advanced medical-grade polymer materials, rising production of customized extruded medical components, increasing focus on sterile and high-quality medical plastic manufacturing, and growing demand for minimally invasive medical device components.
The increasing demand for minimally invasive medical procedures is expected to propel the growth of the medical plastic extrusion market going forward. Minimally invasive medical procedures are specialized treatment techniques that use small incisions or natural body pathways to reduce tissue damage, accelerate recovery, and improve patient outcomes. The demand for minimally invasive medical procedures is increasing due to the growing prevalence of chronic diseases and the rising preference for faster recovery, shorter hospital stays, and cost-effective treatment options. Medical plastic extrusion supports minimally invasive medical procedures by enabling the production of high-precision medical tubing, catheter components, multilumen tubing, and microextrusions that are essential for advanced minimally invasive devices requiring flexibility, precision, and consistent performance within the human body. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, cosmetic surgical procedures increased by 5% between 2023 and 2024, reaching a total of 27,462 procedures in 2024. Therefore, the increasing demand for minimally invasive medical procedures is driving the growth of the medical plastic extrusion market.
Major companies operating in the medical plastic extrusion market are focusing on developing advanced extrusion solutions, such as thin-walled etched polytetrafluoroethylene (PTFE) liners, to improve catheter performance, increase device flexibility, and support precise navigation during minimally invasive medical procedures. A thin-wall etched PTFE liner refers to a precision-extruded fluoropolymer tube manufactured with an ultra-thin wall structure and a chemically etched inner surface to reduce friction, enhance lubricity, and facilitate smoother movement of medical devices such as catheters during complex interventional procedures. For instance, in October 2025, Junkosha, a Japan-based medical polymer and advanced materials company, introduced an ultra-thin wall etched polytetrafluoroethylene (PTFE) liner featuring greater flexibility, enhanced lubricity through a chemically etched inner lumen surface, and high dimensional precision. The innovation is designed to improve catheter performance and enable smoother device navigation in cardiovascular and neurovascular minimally invasive procedures.
In July 2025, Arterex, a US-based provider of medical device development and advanced assembly solutions for the medical device and life sciences industries, acquired Xponent Global, Inc. for an undisclosed amount. Through this acquisition, Arterex expanded its medical extrusion capabilities across North America, strengthening its ability to deliver localized high-precision extrusion solutions while enhancing its manufacturing portfolio for medical device customers. Xponent Global, Inc. is a US-based, ISO 9001:2015-certified manufacturer of extruded tubing for the medical industry.
Major companies operating in the medical plastic extrusion market are Integer Holdings Corporation, Saint-Gobain S.A., Nordson Corporation, Teleflex Incorporated, Putnam Plastics, MicroLumen Inc., Medical Murray Inc., Microspec Corporation, Optinova Holding AB Ltd., Teel Plastics Inc., A.P. Extrusion Inc., RAUMEDIC AG
North America was the dominating region in the medical plastic extrusion market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical plastic extrusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical plastic extrusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical plastic extrusion market consists of sales of multilumen tubes, heat-shrink tubing, drug delivery components, intravenous (IV) and fluid management tubing, and implantable device components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Plastic Extrusion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical plastic extrusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical plastic extrusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical plastic extrusion market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.